Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approaches
Zhenhuan Lu1, Xiaowen Li1, Zhiping Liang1
1Department of Gastrointestinal Surgery, Yuebei People's Hospital, Shaoguan City, Guangdong Province, People's Republic of China.
Pharmacogenomics and Personalized Medicine
|April 8, 2026
Summary
This study developed a predictive model for colorectal cancer (CRC) using routine clinicopathological data. The model accurately predicts tumor mutational burden (TMB), microsatellite instability (MSI), and gene mutation status, aiding clinical decision-making.
Area of Science:
- Oncology
- Bioinformatics
- Machine Learning in Medicine
Background:
- Colorectal cancer (CRC) management requires accurate prediction of key biomarkers.
- Tumor mutational burden (TMB), microsatellite instability (MSI), and specific gene mutations (NTRK/PIK3CA) are critical for treatment selection.
- Predicting these markers using only routine clinicopathological variables remains a challenge.
Purpose of the Study:
- To develop and validate a multi-omics nomogram for predicting TMB, MSI, NTRK/PIK3CA mutation status, and overall survival (OS) in CRC.
- To utilize routine clinicopathological variables for accurate and accessible biomarker prediction.
- To compare the performance of different machine learning algorithms for predictive modeling.
Main Methods:
- Utilized TCGA data (n=398) for training and a prospective cohort (n=120) for external validation.
- Employed feature selection techniques including LASSO regression to identify optimal clinicopathological variables.
- Compared four machine learning algorithms (LR, SVM, DT, RF) using AUC, F1 score, and decision-curve analysis, with the best model validated and calibrated.
Main Results:
- The Random Forest (RF) method achieved the highest predictive power for TMB (AUC=0.9597) and MSI (AUC=0.8225).
- RF also demonstrated strong performance in predicting NTRK and PIK3CA gene status using TMB and MSI indicators.
- The developed models showed high accuracy in predicting key molecular features of colorectal cancer.
Conclusions:
- A robust predictive model using routine clinicopathological variables for TMB, MSI, and gene mutation status in CRC was successfully constructed and validated.
- This model can assist clinicians in identifying high-risk patients and informing treatment strategies.
- Further research with larger sample sizes is recommended to optimize and confirm the model's clinical utility.


